Free tool
FAERS Monitor: Adzenys Xr-Odt
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 204326 or its brand name (Adzenys Xr-Odt, Amphetamine). Reports on generic versions are filed under their own applications.
Reports
6,299
Serious
5,284
84% of reports
Hospitalization
1,474
Death reported
3,007
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- toxicity to various agents1,620
- drug abuse1,301
- completed suicide666
- overdose409
- death354
- cardiac arrest280
- cardio-respiratory arrest266
- drug ineffective237
- respiratory arrest216
- fatigue203
- drug dependence188
- drug interaction185
- nausea166
- substance abuse161
- somnolence159
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 17 |
| 2005 | 12 |
| 2006 | 13 |
| 2007 | 15 |
| 2008 | 16 |
| 2009 | 1 |
| 2010 | 7 |
| 2011 | 42 |
| 2012 | 36 |
| 2013 | 227 |
| 2014 | 264 |
| 2015 | 393 |
| 2016 | 258 |
| 2017 | 327 |
| 2018 | 439 |
| 2019 | 498 |
| 2020 | 507 |
| 2021 | 417 |
| 2022 | 463 |
| 2023 | 512 |
| 2024 | 673 |
| 2025 | 751 |
| 2026 | 411 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,860 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| substance abuseSignal | 161 | 67.4 | 57.7 | 10,256 |
| drug abuseSignal | 1,301 | 53.0 | 50.5 | 65,546 |
| toxicity to various agentsSignal | 1,620 | 32.4 | 31.0 | 49,152 |
| completed suicideSignal | 666 | 26.9 | 25.0 | 16,511 |
| respiratory arrestSignal | 216 | 26.4 | 23.1 | 5,214 |
| cardio-respiratory arrestSignal | 266 | 21.4 | 19.0 | 5,122 |
| cardiac arrestSignal | 280 | 11.4 | 10.1 | 2,636 |
| overdoseSignal | 409 | 6.3 | 5.8 | 1,850 |
| drug dependenceSignal | 188 | 3.9 | 3.4 | 406 |
| drug interactionSignal | 185 | 3.9 | 3.4 | 398 |
| somnolenceSignal | 159 | 2.6 | 2.3 | 161 |
| death | 354 | 1.4 | 1.2 | 37 |
| fatigue | 203 | 0.9 | 0.8 | 4 |
| nausea | 166 | 0.7 | 0.6 | 22 |
| drug ineffective | 237 | 0.6 | 0.5 | 67 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.